| Literature DB >> 30182077 |
Manoj Kumar1, Siddharth Pandey1, Ajay Aggarwal1, Deepanshu Sharma1, Gaurav Garg1, Samarth Agarwal1, Ashish Sharma1, Satyanarayan Sankhwar1.
Abstract
Purpose: To see the 30-day unplanned readmission rates in patients underdoing endo-urological surgeries for upper urinary tract calculi we conducted this retrospective study at King George's Medical University, Lucknow, India. Unplanned readmissions not only add to healthcare costs but also are bothersome for the patients. There are many studies on 30-day unplanned readmissions in general surgical patients. Although similar studies have been done in certain urological procedures, no study has reported readmission rates or its risk factors in patients undergoing surgeries for upper urinary tract calculi. Materials andEntities:
Keywords: Patient readmission; Percutaneous nephrolithotomy; Ureteroscopy; Urinary calculi
Mesh:
Year: 2018 PMID: 30182077 PMCID: PMC6121023 DOI: 10.4111/icu.2018.59.5.321
Source DB: PubMed Journal: Investig Clin Urol ISSN: 2466-0493
Fig. 1Readmission rates over the study period.
Characteristics of patients with 30 days unplanned readmissions
| Characteristic | Value |
|---|---|
| Mean age (y) | 40.59±18.5 |
| Gender (male/female) | Sep-47 |
| Primary surgery | |
| PCNL | 38 (67.9) |
| URS/RIRS | 18 (32.1) |
| Interval in days for readmission | 11.38±6.81 (2–28) |
| Hospital stay in days | 5.93±4.25 (2–20) |
| Etiology for readmission (total=56)a | |
| Hematuria | 17 (30.4) |
| Fever/sepsis | 32 (57.1) |
| Severe stent related symptoms | 8 (14.3) |
| AKI | 1 (1.8) |
| Management (total=56)a | |
| Conservative | 46 (82.1) |
| Clot evacuation | 6 (10.7) |
| Angio-embolization | 8 (14.3) |
| Dialysis | 2 (3.6) |
Values are presented as mean±standard deviation, number only, number (%), or mean±standard deviation (range).
PCNL, percutaneous nephrolithotomy; URS, semi-rigid ureterorenoscopy; RIRS, retrogsrade intra-renal surgery; AKI, acute kidney injury.
aThe total isn't 56 due to multiple responses.
Description of characteristics of patients who underwent PCNL versus URS/RIRS
| Characteristic | PCNL (n=38) | URS/RIRS (n=18) | p-value |
|---|---|---|---|
| Mean age (y) | 40.65±20.37 | 40.44±14.26 | 0.964 |
| Gender (male/female) | 33/5 | 14/4 | 0.388 |
| Interval in days for readmission | 11.68±6.78 (2–28) | 10.72±7.01 (4–27) | 0.626 |
| Hospital stay in days | 6.52±4.24 (2–20) | 4.66±4.10 (2–20) | 0.128 |
| Etiology for readmissiona | |||
| Hematuria | 17 (44.7) | 0 (0.0) | - |
| Fever/sepsis | 18 (47.4) | 14 (77.8) | |
| Severe stent related symptoms | 2 (5.3) | 6 (33.3) | |
| AKI | 1 (2.6) | 0 (0.0) | |
| Management (n=56)a | |||
| Conservative | 29 (76.3) | 17 (94.4) | - |
| Clot evacuation | 6 (15.8) | 0 (0.0) | |
| Angio-embolization | 8 (21.1) | 0 (0.0) | |
| Dialysis | 1 (2.6) | 1 (5.6) | |
| Stone location | |||
| Renal | 38 (100.0) | 1 (5.6) | - |
| Upper ureter | 0 (0.0) | 7 (38.9) | |
| Mid ureter | 0 (0.0) | 6 (33.3) | |
| Distal ureter | 0 (0.0) | 4 (22.2) |
Values are presented as mean±standard deviation, number only, mean±standard deviation (range), or number (%).
PCNL, percutaneous nephrolithotomy; URS, semi-rigid ureterorenoscopy; RIRS, retrograde intra-renal surgery; AKI, acute kidney injury.
aThe total isn't 38 or 18 due to multiple responses.
Analysis of risk factors in patients with and without 30 day unplanned readmissions
| Factor | Readmissions (n=56) | No readmissions (n=3,153) | p-value |
|---|---|---|---|
| Age (y) | 40.59±18.5 | 36.46±15.2 | 0.045 |
| Gender | 0.037 | ||
| Male | 47 (83.9) | 2,247 (71.3) | |
| Female | 9 (16.1) | 906 (28.7) | |
| Age >65 years | 5 (8.9) | 87 (2.8) | 0.006 |
| Current smoking | 10 (17.9) | 213 (6.8) | 0.001 |
| COPD | 8 (14.3) | 67 (2.1) | <0.0001 |
| DM | 15 (26.8) | 337 (10.7) | <0.0001 |
| HTN | 11 (19.6) | 406 (12.9) | 0.136 |
| Prior cardiac illness | 3 (5.4) | 52 (1.6) | 0.034 |
| CLD | 1 (1.8) | 27 (0.9) | 0.459 |
| CKD | 10 (17.9) | 370 (11.7) | 0.160 |
| Bleeding disorders | 1 (1.8) | 5 (0.2) | 0.005 |
| ASA class ≥3 | 15 (26.8) | 191 (6.1) | <0.0001 |
Values are presented as mean±standard deviation or number (%).
COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; CLD, chronic liver disease; CKD, chronic kidney disease; ASA, American Society of Anesthesiologist.
Bivariate analysis of risk-factors for readmission separately for PCNL and URS/RIRS
| Factor | PCNL (n=2,380) | URS/RIRS (n=829) | ||||
|---|---|---|---|---|---|---|
| Readmissions (n=38) | No readmissions (n=2,342) | p-value | Readmissions (n=18) | No readmissions (n=811) | p-value | |
| Age (y) | 40.66±20.37 | 36.62±15.3 | 0.231 | 40.44±14.27 | 36.02±14.9 | 0.210 |
| Gender | 0.037 | 0.518 | ||||
| Male | 33 (86.8) | 1,673 (71.4) | 14 (77.8) | 574 (70.8) | ||
| Female | 5 (13.2) | 669 (28.6) | 4 (22.2) | 237 (29.2) | ||
| Age >65 years | 5 (13.2) | 87 (3.7) | <0.0001 | 0 (0.0) | 21 (2.6) | 0.489 |
| Current smoking | 9 (23.7) | 157 (6.7) | <0.0001 | 1 (5.6) | 56 (6.9) | 0.823 |
| COPD | 8 (21.1) | 49 (2.1) | <0.0001 | 0 (0.0) | 18 (2.2) | 0.523 |
| DM | 10 (26.3) | 252 (10.8) | 0.002 | 5 (27.8) | 85 (10.5) | 0.020 |
| HTN | 7 (18.4) | 298 (12.7) | 0.297 | 2 (11.1) | 108 (13.3) | 0.270 |
| Prior cardiac illness | 3 (7.9) | 36 (1.5) | 0.002 | 0 (0.0) | 16 (2.0) | 0.547 |
| CLD | 1 (2.6) | 21 (0.9) | 0.268 | 0 (0.0) | 6 (0.7) | 0.714 |
| CKD | 8 (21.1) | 285 (12.2) | 0.098 | 2 (11.1) | 85 (10.5) | 0.931 |
| Bleeding disorders | 1 (2.6) | 4 (0.2) | 0.001 | 0 (0.0) | 1 (0.1) | 0.881 |
| ASA class ≥3 | 11 (28.9) | 145 (6.2) | <0.0001 | 4 (22.2) | 64 (7.9) | 0.004 |
Values are presented as mean±standard deviation or number (%).
PCNL, percutaneous nephrolithotomy; URS, semi-rigid ureterorenoscopy; RIRS, retrograde intra-renal surgery; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; CLD, chronic liver disease; CKD, chronic kidney disease; ASA, American Society of Anesthesiologist.
Multivariate risk adjusted logistic regression analysis of risk factors for unplanned 30 days readmissions
| Risk factor | p-value | OR (95% CI) |
|---|---|---|
| Male | 0.054 | 0.491 (0.238–1.014) |
| Age >65 years | 0.083 | 0.398 (0.140–1.128) |
| H/O smoking | 0.852 | 1.103 (0.394–3.086) |
| COPD | 0.305 | 0.533 (0.161–1.771) |
| DM | 0.551 | 0.736 (0.283–1.914) |
| HTN | 0.564 | 0.749 (0.290–1.934) |
| CKD | 0.238 | 1.740 (0.693–4.363) |
| ASA class ≥3 | 0.002 | 0.188 (0.064–0.553) |
OR, odds ratio; CI, confidence interval; H/O, past history of smoking; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; CKD, chronic kidney disease; ASA, American Society of Anesthesiologist.